 NEW YORK, NY and SAN DIEGO, CA, Nov. 18, 2020 GLOBE NEWSWIRE -- via NewMediaWire -- As previously announced, during April 2020, Tauriga Sciences, Inc. OTCQB: TAUG Tauriga and Aegea Biotechnologies, Inc. Aegea have entered into a collaboration agreement to develop COVID-19 novel coronavirus assays. Aegea has made substantial progress in designing and developing two different, next generation assays for SARS-CoV-2. 